• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病缺血性心律失常的机制:大规模计算研究。

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.

机构信息

Department of Computer Science, University of Oxford, Oxford, UK.

Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.

出版信息

Cardiovasc Res. 2024 Jul 2;120(8):914-926. doi: 10.1093/cvr/cvae086.

DOI:10.1093/cvr/cvae086
PMID:38646743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11218689/
Abstract

AIMS

Lethal arrhythmias in hypertrophic cardiomyopathy (HCM) are widely attributed to myocardial ischaemia and fibrosis. How these factors modulate arrhythmic risk remains largely unknown, especially as invasive mapping protocols are not routinely used in these patients. By leveraging multiscale digital twin technologies, we aim to investigate ischaemic mechanisms of increased arrhythmic risk in HCM.

METHODS AND RESULTS

Computational models of human HCM cardiomyocytes, tissue, and ventricles were used to simulate outcomes of Phase 1A acute myocardial ischaemia. Cellular response predictions were validated with patch-clamp studies of human HCM cardiomyocytes (n = 12 cells, N = 5 patients). Ventricular simulations were informed by typical distributions of subendocardial/transmural ischaemia as analysed in perfusion scans (N = 28 patients). S1-S2 pacing protocols were used to quantify arrhythmic risk for scenarios in which regions of septal obstructive hypertrophy were affected by (i) ischaemia, (ii) ischaemia and impaired repolarization, and (iii) ischaemia, impaired repolarization, and diffuse fibrosis. HCM cardiomyocytes exhibited enhanced action potential and abnormal effective refractory period shortening to ischaemic insults. Analysis of ∼75 000 re-entry induction cases revealed that the abnormal HCM cellular response enabled establishment of arrhythmia at milder ischaemia than otherwise possible in healthy myocardium, due to larger refractoriness gradients that promoted conduction block. Arrhythmias were more easily sustained in transmural than subendocardial ischaemia. Mechanisms of ischaemia-fibrosis interaction were strongly electrophysiology dependent. Fibrosis enabled asymmetric re-entry patterns and break-up into sustained ventricular tachycardia.

CONCLUSION

HCM ventricles exhibited an increased risk to non-sustained and sustained re-entry, largely dominated by an impaired cellular response and deleterious interactions with the diffuse fibrotic substrate.

摘要

目的

肥厚型心肌病(HCM)中的致死性心律失常广泛归因于心肌缺血和纤维化。这些因素如何调节心律失常风险在很大程度上仍然未知,特别是因为在这些患者中通常不使用侵入性映射方案。通过利用多尺度数字孪生技术,我们旨在研究 HCM 中增加心律失常风险的缺血机制。

方法和结果

使用人类 HCM 心肌细胞、组织和心室的计算模型来模拟 1A 期急性心肌缺血的结果。通过对人类 HCM 心肌细胞(n = 12 个细胞,N = 5 个患者)的膜片钳研究验证了细胞反应预测。心室模拟基于灌注扫描中分析的心内膜/中层缺血的典型分布(N = 28 个患者)。S1-S2 起搏方案用于量化当间隔阻塞性肥厚区域受到以下情况影响时的心律失常风险:(i)缺血,(ii)缺血和复极化受损,以及(iii)缺血、复极化受损和弥漫性纤维化。HCM 心肌细胞对缺血性损伤表现出增强的动作电位和异常的有效不应期缩短。对约 75000 个折返诱导病例的分析表明,由于较大的不应期梯度促进传导阻滞,异常的 HCM 细胞反应使心律失常在比健康心肌更轻微的缺血条件下得以建立,这是因为正常心肌不可能建立心律失常。与心内膜下缺血相比,透壁性缺血更容易维持心律失常。缺血-纤维化相互作用的机制强烈依赖于电生理学。纤维化使非对称折返模式和转化为持续室性心动过速成为可能。

结论

HCM 心室表现出非持续和持续折返的风险增加,主要由细胞反应受损和与弥漫性纤维化基质的有害相互作用引起。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/eb7d00a12fee/cvae086f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/02d87c768c39/cvae086_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/a2adda14e4f2/cvae086f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/fa748e0a81fe/cvae086f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/d9b36311ea47/cvae086f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/3d76892b2cf4/cvae086f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/963c9627274b/cvae086f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/eb7d00a12fee/cvae086f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/02d87c768c39/cvae086_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/a2adda14e4f2/cvae086f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/fa748e0a81fe/cvae086f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/d9b36311ea47/cvae086f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/3d76892b2cf4/cvae086f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/963c9627274b/cvae086f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d99/11218689/eb7d00a12fee/cvae086f6.jpg

相似文献

1
Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study.肥厚型心肌病缺血性心律失常的机制:大规模计算研究。
Cardiovasc Res. 2024 Jul 2;120(8):914-926. doi: 10.1093/cvr/cvae086.
2
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy.应激心电图中肥厚型心肌病 T 波假性正常化的电生理机制。
Comput Biol Med. 2024 Feb;169:107829. doi: 10.1016/j.compbiomed.2023.107829. Epub 2023 Dec 7.
3
Genotype and arrhythmic risk in patients with apical hypertrophic cardiomyopathy.肥厚型心肌病患者的基因型与心律失常风险
Heart. 2025 Aug 26;111(18):859-866. doi: 10.1136/heartjnl-2024-325218.
4
Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation.预防与气管插管血流动力学反应相关发病的药理制剂。
Cochrane Database Syst Rev. 2013 Jul 3;2013(7):CD004087. doi: 10.1002/14651858.CD004087.pub2.
5
Effect of obesity on myocardial tissue characteristics in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance-based study.肥胖对肥厚型心肌病患者心肌组织特征的影响:一项基于心血管磁共振成像的研究
J Cardiovasc Magn Reson. 2025;27(1):101903. doi: 10.1016/j.jocmr.2025.101903. Epub 2025 May 2.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.药物难治性或药物不耐受性肥厚型心肌病的起搏治疗
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008523. doi: 10.1002/14651858.CD008523.pub2.
8
Pyruvate Dehydrogenase Kinase 4 Underlies the Metabolic Disorder of Cardiomyocytes in Patients With Hypertrophic Cardiomyopathy From Hypertrophy to Heart Failure.丙酮酸脱氢酶激酶4是肥厚型心肌病患者从肥厚到心力衰竭过程中心肌细胞代谢紊乱的基础。
J Am Heart Assoc. 2025 Aug 5;14(15):e041401. doi: 10.1161/JAHA.125.041401. Epub 2025 Jul 29.
9
Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy.年轻至中年肥厚型心肌病患者的心肌纤维化加速
J Cardiovasc Magn Reson. 2024;26(2):101072. doi: 10.1016/j.jocmr.2024.101072. Epub 2024 Aug 2.
10
Cardiopulmonary exercise testing parameters in healthy athletes vs. equally fit individuals with hypertrophic cardiomyopathy.健康运动员与同等健康的肥厚型心肌病患者的心肺运动测试参数对比
Eur J Prev Cardiol. 2025 May 5. doi: 10.1093/eurjpc/zwaf177.

引用本文的文献

1
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy.信号通路在肥厚型心肌病心肌纤维化中的作用
Rev Cardiovasc Med. 2025 Feb 21;26(2):27152. doi: 10.31083/RCM27152. eCollection 2025 Feb.
2
Storytelling of Hypertrophic Cardiomyopathy Discovery.肥厚型心肌病发现的故事讲述
J Cardiovasc Dev Dis. 2024 Sep 28;11(10):300. doi: 10.3390/jcdd11100300.

本文引用的文献

1
Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy.应激心电图中肥厚型心肌病 T 波假性正常化的电生理机制。
Comput Biol Med. 2024 Feb;169:107829. doi: 10.1016/j.compbiomed.2023.107829. Epub 2023 Dec 7.
2
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
3
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.
肥厚型心肌病中心肌缺血的机制及预后影响
Int J Cardiovasc Imaging. 2023 Oct;39(10):1979-1996. doi: 10.1007/s10554-023-02894-y. Epub 2023 Jun 26.
4
The mechanisms of potassium loss in acute myocardial ischemia: New insights from computational simulations.急性心肌缺血中钾流失的机制:来自计算模拟的新见解
Front Physiol. 2023 Feb 27;14:1074160. doi: 10.3389/fphys.2023.1074160. eCollection 2023.
5
The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.运动试验异常与儿童肥厚型心肌病猝死和无移植生存的相关性及患病率。
Circulation. 2023 Feb 28;147(9):718-727. doi: 10.1161/CIRCULATIONAHA.122.062699. Epub 2022 Nov 6.
6
Analysis of vulnerability to reentry in acute myocardial ischemia using a realistic human heart model.利用现实人心血管模型分析急性心肌缺血再灌注损伤易感性。
Comput Biol Med. 2022 Feb;141:105038. doi: 10.1016/j.compbiomed.2021.105038. Epub 2021 Nov 17.
7
Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.肥厚型心肌病中肌节变异与心肌氧合的关联:来自一种新型氧敏感心血管磁共振方法的见解
Circulation. 2021 Nov 16;144(20):1656-1658. doi: 10.1161/CIRCULATIONAHA.121.054015. Epub 2021 Nov 15.
8
Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.肥厚型心肌病突变携带者的心肌灌注缺陷。
J Am Heart Assoc. 2021 Aug 3;10(15):e020227. doi: 10.1161/JAHA.120.020227. Epub 2021 Jul 27.
9
Size matters in atrial fibrillation: the underestimated importance of reduction of contiguous electrical mass underlying the effectiveness of catheter ablation.心房颤动中大小很重要:减少连续电质量对导管消融有效性的重要性被低估了。
Europace. 2021 Nov 8;23(11):1698-1707. doi: 10.1093/europace/euab078.
10
Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis.小血管疾病:肥厚型心肌病表型的另一个组成部分,不一定与纤维化相关。
J Clin Med. 2021 Feb 4;10(4):575. doi: 10.3390/jcm10040575.